10 20 30 40 50 60 70 80 3H3C - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER TRANSFERASE 16-APR-09 3H3C
TITLE CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE- TITLE 2 SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN TYROSINE KINASE 2 BETA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FOCAL ADHESION KINASE 2, FADK 2, PROLINE-RICH COMPND 5 TYROSINE KINASE 2, CELL ADHESION KINASE BETA, CAK BETA, COMPND 6 CALCIUM-DEPENDENT TYROSINE KINASE, CADTK, RELATED ADHESION COMPND 7 FOCAL TYROSINE KINASE, RAFTK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2B, FAK2, PYK2, RAFTK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469
KEYWDS PYK2, KINASE, ALTERNATIVE SPLICING, ATP-BINDING, CELL KEYWDS 2 MEMBRANE, CYTOPLASM, MEMBRANE, NUCLEOTIDE-BINDING, KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM, TRANSFERASE, TYROSINE-PROTEIN KEYWDS 4 KINASE
EXPDTA X-RAY DIFFRACTION
AUTHOR S.HAN,A.MISTRY
REVDAT 2 07-JUL-09 3H3C 1 JRNL REVDAT 1 26-MAY-09 3H3C 0
JRNL AUTH D.P.WALKER,M.P.ZAWISTOSKI,M.A.MCGLYNN,J.C.LI, JRNL AUTH 2 D.W.KUNG,P.C.BONNETTE,A.BAUMANN,L.BUCKBINDER, JRNL AUTH 3 J.A.HOUSER,J.BOER,A.MISTRY,S.HAN,L.XING, JRNL AUTH 4 A.GUZMAN-PEREZ JRNL TITL SULFOXIMINE-SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE JRNL TITL 2 ANALOGS AS INHIBITORS OF PROLINE-RICH TYROSINE JRNL TITL 3 KINASE 2 (PYK2) SHOW REDUCED HERG ACTIVITY. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 3253 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19428251 JRNL DOI 10.1016/J.BMCL.2009.04.093
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 18043 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 975 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1266 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2134 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.85000 REMARK 3 B22 (A**2) : -0.91000 REMARK 3 B33 (A**2) : 1.74000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.20000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.225 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.135 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.893 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2238 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3036 ; 1.629 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 261 ; 5.924 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 331 ; 0.126 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1636 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 983 ; 0.221 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 74 ; 0.148 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 51 ; 0.224 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.047 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1313 ; 1.103 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2138 ; 2.032 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 925 ; 2.813 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 898 ; 4.501 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3H3C COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-09. REMARK 100 THE RCSB ID CODE IS RCSB052639.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.542 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19055 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.49600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M MGCL2, 20-27% PEG3350, 1MM REMARK 280 TCEP, 0.1M BIS-TRIS, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.41500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 571 REMARK 465 ARG A 572 REMARK 465 TYR A 573 REMARK 465 ILE A 574 REMARK 465 GLU A 575 REMARK 465 ASP A 576 REMARK 465 GLU A 577 REMARK 465 ASP A 578 REMARK 465 TYR A 579 REMARK 465 TYR A 580 REMARK 465 LYS A 581 REMARK 465 ALA A 582 REMARK 465 SER A 583 REMARK 465 VAL A 584
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 462 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP A 663 CB - CG - OD2 ANGL. DEV. = 7.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 417 76.68 -119.91 REMARK 500 ASN A 446 156.03 -38.08 REMARK 500 GLU A 496 -129.04 37.93 REMARK 500 ASN A 544 41.86 36.27 REMARK 500 ASP A 549 58.06 -147.07 REMARK 500 ASP A 567 -75.33 -83.79 REMARK 500 PHE A 568 138.67 -27.66 REMARK 500 ARG A 586 70.60 25.00 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 3 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 4 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 5 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P1E A 999
DBREF 3H3C A 416 692 UNP Q14289 FAK2_HUMAN 416 692
SEQRES 1 A 277 PRO GLN TYR GLY ILE ALA ARG GLU ASP VAL VAL LEU ASN SEQRES 2 A 277 ARG ILE LEU GLY GLU GLY PHE PHE GLY GLU VAL TYR GLU SEQRES 3 A 277 GLY VAL TYR THR ASN HIS LYS GLY GLU LYS ILE ASN VAL SEQRES 4 A 277 ALA VAL LYS THR CYS LYS LYS ASP CYS THR LEU ASP ASN SEQRES 5 A 277 LYS GLU LYS PHE MET SER GLU ALA VAL ILE MET LYS ASN SEQRES 6 A 277 LEU ASP HIS PRO HIS ILE VAL LYS LEU ILE GLY ILE ILE SEQRES 7 A 277 GLU GLU GLU PRO THR TRP ILE ILE MET GLU LEU TYR PRO SEQRES 8 A 277 TYR GLY GLU LEU GLY HIS TYR LEU GLU ARG ASN LYS ASN SEQRES 9 A 277 SER LEU LYS VAL LEU THR LEU VAL LEU TYR SER LEU GLN SEQRES 10 A 277 ILE CYS LYS ALA MET ALA TYR LEU GLU SER ILE ASN CYS SEQRES 11 A 277 VAL HIS ARG ASP ILE ALA VAL ARG ASN ILE LEU VAL ALA SEQRES 12 A 277 SER PRO GLU CYS VAL LYS LEU GLY ASP PHE GLY LEU SER SEQRES 13 A 277 ARG TYR ILE GLU ASP GLU ASP TYR TYR LYS ALA SER VAL SEQRES 14 A 277 THR ARG LEU PRO ILE LYS TRP MET SER PRO GLU SER ILE SEQRES 15 A 277 ASN PHE ARG ARG PHE THR THR ALA SER ASP VAL TRP MET SEQRES 16 A 277 PHE ALA VAL CYS MET TRP GLU ILE LEU SER PHE GLY LYS SEQRES 17 A 277 GLN PRO PHE PHE TRP LEU GLU ASN LYS ASP VAL ILE GLY SEQRES 18 A 277 VAL LEU GLU LYS GLY ASP ARG LEU PRO LYS PRO ASP LEU SEQRES 19 A 277 CYS PRO PRO VAL LEU TYR THR LEU MET THR ARG CYS TRP SEQRES 20 A 277 ASP TYR ASP PRO SER ASP ARG PRO ARG PHE THR GLU LEU SEQRES 21 A 277 VAL CYS SER LEU SER ASP VAL TYR GLN MET GLU LYS ASP SEQRES 22 A 277 ILE ALA MET GLU
HET SO4 A 1 5 HET SO4 A 2 5 HET SO4 A 3 5 HET SO4 A 4 5 HET SO4 A 5 5 HET P1E A 999 31
HETNAM SO4 SULFATE ION HETNAM P1E 4-{[4-{[(1R,2R)-2-(DIMETHYLAMINO)CYCLOPENTYL]AMINO}-5- HETNAM 2 P1E (TRIFLUOROMETHYL)PYRIMIDIN-2-YL]AMINO}-N- HETNAM 3 P1E METHYLBENZENESULFONAMIDE
FORMUL 2 SO4 5(O4 S 2-) FORMUL 7 P1E C19 H25 F3 N6 O2 S FORMUL 8 HOH *29(H2 O)
HELIX 1 1 ALA A 421 GLU A 423 5 3 HELIX 2 2 THR A 464 LEU A 481 1 18 HELIX 3 3 GLU A 509 ASN A 517 1 9 HELIX 4 4 LYS A 522 ILE A 543 1 22 HELIX 5 5 ALA A 551 ARG A 553 5 3 HELIX 6 6 PRO A 588 MET A 592 5 5 HELIX 7 7 SER A 593 ARG A 600 1 8 HELIX 8 8 THR A 603 SER A 620 1 18 HELIX 9 9 GLU A 630 LYS A 632 5 3 HELIX 10 10 ASP A 633 LYS A 640 1 8 HELIX 11 11 PRO A 651 TRP A 662 1 12 HELIX 12 12 ASP A 665 ARG A 669 5 5 HELIX 13 13 ARG A 671 GLU A 692 1 22
SHEET 1 A 5 VAL A 425 GLY A 434 0 SHEET 2 A 5 GLY A 437 THR A 445 -1 O GLU A 441 N ARG A 429 SHEET 3 A 5 LYS A 451 LYS A 457 -1 O ILE A 452 N TYR A 444 SHEET 4 A 5 TRP A 499 GLU A 503 -1 O ILE A 500 N LYS A 457 SHEET 5 A 5 LEU A 489 ILE A 493 -1 N ILE A 493 O TRP A 499 SHEET 1 B 2 ILE A 555 SER A 559 0 SHEET 2 B 2 CYS A 562 LEU A 565 -1 O LYS A 564 N LEU A 556
SITE 1 AC1 7 GLY A 434 PHE A 435 LYS A 457 ASP A 567 SITE 2 AC1 7 PHE A 568 HOH A 694 P1E A 999 SITE 1 AC2 3 SER A 620 LYS A 623 ASP A 648 SITE 1 AC3 2 HOH A 23 HIS A 483 SITE 1 AC4 2 HIS A 485 GLN A 532 SITE 1 AC5 3 HOH A 19 LYS A 522 VAL A 523 SITE 1 AC6 14 SO4 A 1 PRO A 416 TYR A 418 LEU A 431 SITE 2 AC6 14 MET A 502 GLU A 503 LEU A 504 TYR A 505 SITE 3 AC6 14 GLY A 508 GLU A 509 HIS A 512 LEU A 556 SITE 4 AC6 14 ASP A 567 HOH A 694
CRYST1 37.281 92.830 42.843 90.00 92.64 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.026823 0.000000 0.001235 0.00000
SCALE2 0.000000 0.010772 0.000000 0.00000
SCALE3 0.000000 0.000000 0.023366 0.00000